Research Article
Innovations and Challenges by Applying Sublingual Laser Blood Irradiation in Juvenile Idiopathic Arthritis
Table 2
Evolution from baseline of ACR core set data at the end of the sublingual laser blood irradiation.
| | Variable | Group I ( = 36) | Group II ( = 36) | Group III ( = 33) | | Baseline | Weeks 24 | Baseline | Weeks 24 | Baseline | Weeks 24 |
| | ACR Pedi 30 response number (%) | — | 30 (83.33) | — | 20 (55.55) | — | 19 (57.57) |
| | ACR core set of variables | | Number of joints with active arthritis | 7.58 ± 2.32 | 3.94 ± 1.14 ( = 0.001) | 7.5 ± 1.16 | 6.83 ± 1.23 ( = 0.02) | 7.42 ± 2.66 | 6.66 ± 1.21 ( = 0.13) | | Number of joints with limited range of motion | 17.63 ± 5.31 | 9.30 ± 2.81 ( = 0.001) | 17.69 ± 14.6 | 13.80 ± 8.00 ( = 0.16) | 17.09 ± 3.66 | 15.46 ± 2.65 ( = 0.04) | | Physician's global assessment of overall disease activity | 56.11 ± 10.76 | 31.25 ± 9.05 ( = 0.001) | 55.15 ± 13.22 | 47.87 ± 12.69 ( = 0.01) | 56.66 ± 7.52 | 51.46 ± 9.85 ( = 0.01) | | Parent of patient global assessment of overall well-being | 58.05 ± 1.04 | 33.88 ± 0.33 ( = 0.001) | 52.22 ± 13.01 | 46.66 ± 13.90 ( = 0.09) | 60.30 ± 11.69 | 53.46 ± 14.9 ( = 0.03) | | CHAQ-DI score | 1.69 ± 0.68 | 1.05 ± 0.15 ( = 0.001) | 1.55 ± 0.56 | 1.22 ± 0.50 ( = 0.01) | 1.50 ± 0.54 | 1.20 ± 0.60 ( = 0.03) | | ESR (mm/hr) | 42.38 ± 23.35 | 17.58 ± 0.98 ( = 0.001) | 42.22 ± 6.92 | 38.55 ± 6.85 ( = 0.02) | 41.83 ± 10.28 | 36.80 ± 6.50 ( = 0.02) |
|
|
